Navigation Links
Bush Supports Restriction to ‘Morning–After’ Pll

Restricted access to emergency contraception for minors has been supported by President George W. Bush on Monday while drug regulators weigh wider access to the "morning-after"// pill.

Bush’s statement on this politically charged issue, has delayed a Senate confirmation vote on his nominee Andrew von Eschenbach to head the U.S Food and Drug Administration.

Von Eschenbach, as acting FDA commissioner has supported nonprescription emergency contraception sales for adults which earned him the opposition of some conservatives. Bush said, "I believe that Plan B ought to require a prescription for minors. That's what I believe."

Barr Pharmaceutical’s two attempts to win government approval to sell its Plan B drug widely without a prescription have been unsuccessful. In 2003 it applied for approval of the drug for all women of all ages but was rejected. In its second attempt approval for women 16 and older was applied. FDA has postponed its decision.

Democrats who assert that the decision on Plan B has been delayed for political reasons has held up Von Eschenbach's nomination to the permanent job of commissioner up for months.

According to Von Eschenbach Plan B could be used safely and effectively for women 18 and older provided younger people could not buy it without a doctor's note.

Plan B was approved as a prescription drug in 1999. It is a set of two high-dose hormone pills which can prevent pregnancy provided it is taken within 72 hours of sexual intercourse.

Supporters of the wide access to the drug include the American Medical Association and Planned Parenthood who say that easing access to the drug would lead to fewer abortions, but opponents argue it will spur promiscuity. Planned Parenthood President Cecile Richards said, "If the president's comments are an indication that they're final going to move on this, this would be great progress."

Von Eschenbach and two previous co mmissioners said that they were not directed by the White House on the issue. However the Family Research Council and other conservative groups which usually support Bush are opposing the nomination because von Eschenbach is moving ahead on Plan B, as well as continuing to allow the abortion pill RU-486 to remain on the market.

The group's vice president for government affairs, Tom McClusky, said, "Dr. von Eschenbach has shown a history of ignoring any concern for women's health in exchange for political expediency."

The FDA said that Plan B mainly worked by blocking the release of an egg from an ovary. The drug may also prevent the union of an egg and sperm. However RU-486 works by blocking a hormone which keeps a fertilized egg implanted in the uterus.
'"/>




Related medicine news :

1. Google Supports Indians Novel Literacy Drive
2. Actor Anil Kapoor Supports Birth Registration Cause
3. AMA Supports Tax Penalty for Uninsured Americans
4. Church Supports HIV Test Before Marriage
5. EHRVA Supports EHR Product Certification
6. AMA Supports Hospital Junk Food Review
7. Ontario Supports OHIP’s Rejection of Claim by North York Ma
8. Minister Supports Private Sector In NHS
9. FDA Imposes New Restrictions On Roches Accutane
10. Drink till you drop dead in English Pubs- Restriction on Timings Lifted
11. Bird Flu Restrictions To Be Lifted In Scotland
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
Breaking Medicine Technology: